HOPKINTON, Mass. — Caliper Life Sciences, Inc. (Nasdaq:CALP – News), a leading provider of tools and services for drug discovery and life sciences research, and its wholly owned subsidiary Xenogen Corporation, today announced the filing of a patent infringement lawsuit in the U.S. District Court for the Eastern District of Texas. In the suit, filed […]
Consolidates the Leading Intellectual Property Positions and Technologies In Fluorescence In Vivo Imaging Agen BEDFORD, MA — VisEn Medical Inc., a leader in fluorescence in vivo imaging from research through medicine, announced today that it has acquired the fluorescence imaging agent intellectual property portfolios and related technology platforms from Bayer Schering Pharma AG, Germany. The […]
Biotechnology Leader Provides Technology of Choice for Leading Pharmaceutical Industry Scientists WOBURN, Mass.–Cambridge Research & Instrumentation, Inc. (CRi), a leader in biomedical imaging, announced that 18 out of the top 20 pharmaceutical companies worldwide are using CRi’s optical imaging systems. These top pharmaceutical companies, ranked by revenue by Med Ad News in September 2009, have […]
Advanced Tools for Quantitative 3D Molecular Imaging, Bioluminescence and Fluorescence Spectral Unmixing of Small Animals HOPKINTON, Mass. — Caliper Life Sciences, Inc. (Nasdaq: CALP – News), a leading provider of tools and services for drug discovery and life sciences research, today introduced Living Image 4.0 software for IVIS® in vivo imaging systems. Living Image software […]
MONTREAL, CANADA–ART Advanced Research Technologies Inc. (ART) (TSX:ARA – News), a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, announces that its strategic review process has culminated in ART entering into an agreement today with Dorsky Worldwide Corp. (“Dorsky”) to restructure ART’s balance sheet and […]
Expands VisEn’s Fluorescence Molecular Imaging Agent Portfolio to Enable Enhanced Multiplexed Readouts of Key Biomarkers in Research and Drug Development BEDFORD, Mass. — VisEn Medical Inc., a leader in fluorescence in vivo imaging from research through medicine, announced today the commercial launch of its new OsteoSense® 800 imaging agent for targeting areas of bone turnover […]
MONTREAL, QUEBEC, CANADA — ART Advanced Research Technologies Inc. (ART) (TSX:ARA – News), a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, announced today that in view of the Company’s ongoing financial needs, its Board of Directors has initiated a process to explore strategic options […]
XenoLight Rediject D-Luciferin Ultra Further Enhances Caliper’s Unique Offering for Small Animal Imaging Hopkinton, Mass. — Caliper Life Sciences, Inc. (Nasdaq: CALP – News), a leading provider of tools and services for drug discovery and life sciences research, today introduced a series of XenoLight Rediject reagents at the World Molecular Imaging Congress (WMIC) in Montreal, […]
ART Advanced Research Technologies Launches Optix MX3 Molecular Imaging System at WMIC2009 Optix MX3 offers a new benchmark for imaging performance and versatility in the preclinical phases of drug development MONTREAL, CANADA – ART Advanced Research Technologies Inc. (“ART”) (TSX:ARA), a Canadian medical device company and a leader in optical molecular imaging products for the […]
Philips and Bruker BioSpin Sign Memorandum of Understanding to Bring New Imaging Technology to the Preclinical Market MONTREAL — At the 2009 World Molecular Imaging Congress (WMIC) in Montreal, Royal Philips Electronics (NYSE: PHG, AEX: PHI) and Bruker BioSpin, a division of Bruker Corporation (NASDAQ: BRKR), today announced that they have signed a memorandum of […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
